Laboratoire de Cristallographie et RMN Biologiques, CNRS, UMR 8015, Université Paris Descartes, 75006 Paris, France.
J Biol Chem. 2010 Mar 12;285(11):8422-33. doi: 10.1074/jbc.M109.089128. Epub 2010 Jan 6.
We report the first crystal structure of a 1:2 hormone.receptor complex that involves prolactin (PRL) as the ligand, at 3.8-A resolution. Stable ternary complexes were obtained by generating affinity-matured PRL variants harboring an N-terminal tail from ovine placental lactogen, a closely related PRL receptor (PRLR) ligand. This structure allows one to draw up an exhaustive inventory of the residues involved at the PRL.PRLR site 2 interface, consistent with all previously reported site-directed mutagenesis data. We propose, with this description, an interaction model involving three structural components of PRL site 2 ("three-pin plug"): the conserved glycine 129 of helix alpha3, the hydrogen bond network involving surrounding residues (glycine cavity), and the N terminus. The model provides a molecular basis for the properties of the different PRL analogs designed to date, including PRLR antagonists. Finally, comparison of our 1:2 PRL.PRLR(2) structure with those of free PRL and its 1:1 complex indicates that the structure of PRL undergoes significant changes when binding the first, but not the second receptor. This suggests that the second PRLR moiety adapts to the 1:1 complex rather than the opposite. In conclusion, this structure will be a useful guiding tool for further investigations of the molecular mechanisms involved in PRLR dimerization and activation, as well as for the optimization of PRLR antagonists, an emerging class of compounds with high therapeutic potential against breast and prostate cancer.
我们报告了第一个涉及催乳素(PRL)作为配体的 1:2 激素-受体复合物的晶体结构,分辨率为 3.8-A。通过生成具有来自绵羊胎盘催乳素(与 PRL 受体(PRLR)配体密切相关)N 端尾巴的亲和力成熟的 PRL 变体,获得了稳定的三元复合物。该结构允许人们详细列出涉及 PRL.PRLR 位点 2 界面的残基,与所有先前报道的定点突变数据一致。我们提出了一个涉及 PRL 位点 2 的三个结构成分的相互作用模型(“三销塞”):α3 螺旋的保守甘氨酸 129、涉及周围残基的氢键网络(甘氨酸腔)和 N 端。该模型为迄今为止设计的不同 PRL 类似物的特性提供了分子基础,包括 PRLR 拮抗剂。最后,将我们的 1:2 PRL.PRLR(2)结构与游离 PRL 及其 1:1 复合物的结构进行比较表明,当结合第一个而不是第二个受体时,PRL 的结构会发生显着变化。这表明第二个 PRLR 部分适应 1:1 复合物而不是相反。总之,该结构将成为进一步研究 PRLR 二聚化和激活涉及的分子机制以及优化 PRLR 拮抗剂的有用指导工具,PRLR 拮抗剂是一类具有治疗乳腺癌和前列腺癌高潜力的新兴化合物。